What changed today in Regulatory: 1 new study, 1 recall record, 1 safety alert

Why this matters

Federal Register documents and FDA notices can change compliance obligations, deadlines and enforcement priorities for pharmacies, compounders and prescribers.

Source file

1. [1]
   Glucagon-Like Peptide-1 Receptor Agonist-Associated Hepatotoxicity (opens the source in a new tab)

   Peer reviewedClinical therapeuticsSep 24, 2026

2. [2]
   G. L. Mezzetta Inc. Announces Recall of Mezzetta Brand Golden Greek Peperoncini (Medium Heat) Due to Presence of Pest Contaminant in the Jar (opens the source in a new tab)

   Official noticeU.S. Food and Drug AdministrationSep 26, 2026

3. [3]
   Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters (opens the source in a new tab)

   Official noticeU.S. Food and Drug Administration (MedWatch)Sep 25, 2026

4. [4]
   FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s (opens the source in a new tab)

   News reportingAmerican Med Spa AssociationSep 24, 2026Industry coverage — headline and link only

5. [5]
   Pharmacy Law Lowdown: FDA’s Evaluation of Peptides (opens the source in a new tab)

   News reportingDrug TopicsSep 25, 2026Industry coverage — headline and link only

6. [6]
   Elevance cracks down on hospital billing for off-campus care (opens the source in a new tab)

   News reportingHealthcare DiveSep 30, 2026Industry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.

Update timeline

1. Oct 1, 2026, 5:05 AM EDTFirst published.
2. Oct 1, 2026, 5:08 AM EDTAdded 1 new official record.